1. Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial. Issue 2 (February 2016) Authors: Mulenga, Veronica; Musiime, Victor; Kekitiinwa, Adeodata; Cook, Adrian D; Abongomera, George; Kenny, Julia; Chabala, Chisala; Mirembe, Grace; Asiimwe, Alice; Owen-Powell, Ellen; Burger, David; McIlleron, Helen; Klein, Nigel; Chintu, Chifumbe; Thomason, Margaret J; Kityo, Cissy; Walker, A Sarah; G... Journal: Lancet infectious diseases Issue: Volume 16:Issue 2(2016:Feb.) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acceptability of Lopinavir/R Pellets (Minitabs), Tablets and Syrups in HIV-Infected Children. Issue 7 (October 2016) Authors: Kekitiinwa, Adeodata; Musiime, Victor; Thomason, Margaret J; Mirembe, Grace; Lallemant, Marc; Nakalanzi, Sarah; Baptiste, David; Walker, A Sarah; Gibb, Diana M; Judd, Ali Journal: Antiviral therapy Issue: Volume 21:Issue 7(2016) Page Start: 579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial. Issue 10 (October 2019) Authors: Maitland, Kathryn; Olupot-Olupot, Peter; Kiguli, Sarah; Chagaluka, George; Alaroker, Florence; Opoka, Robert O; Mpoya, Ayub; Walsh, Kevin; Engoru, Charles; Nteziyaremye, Julius; Mallewa, Machpherson; Kennedy, Neil; Nakuya, Margaret; Namayanja, Cate; Kayaga, Julianne; Nabawanuka, Eva; Sennyondo, T... Journal: Lancet Issue: Volume 7:Issue 10(2019) Page Start: e1435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial. Issue 5 (May 2018) Authors: Mallewa, Jane; Szubert, Alexander J; Mugyenyi, Peter; Chidziva, Ennie; Thomason, Margaret J; Chepkorir, Priscilla; Abongomera, George; Baleeta, Keith; Etyang, Anthony; Warambwa, Colin; Melly, Betty; Mudzingwa, Shepherd; Kelly, Christine; Agutu, Clara; Wilkes, Helen; Nkomani, Sanele; Musiime, Vict... Journal: Lancet Issue: Volume 5:Issue 5(2018) Page Start: e231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial. (4th March 2018) Authors: Siika, Abraham; McCabe, Leanne; Bwakura-Dangarembizi, Mutsa; Kityo, Cissy; Mallewa, Jane; Berkley, Jay; Maitland, Kath; Griffiths, Anna; Baleeta, Keith; Mudzingwa, Shepherd; Abach, James; Nathoo, Kusum; Thomason, Margaret J; Prendergast, Andrew J; Walker, Ann Sarah; Gibb, Diana M Journal: Clinical infectious diseases Issue: Volume 66(2018)Supplement 2 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018) Authors: Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I; Agweng, ... Journal: Lancet infectious diseases Issue: Volume 18:Issue 1(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial. Issue 1 (January 2018) Authors: Hakim, James G; Thompson, Jennifer; Kityo, Cissy; Hoppe, Anne; Kambugu, Andrew; van Oosterhout, Joep J; Lugemwa, Abbas; Siika, Abraham; Mwebaze, Raymond; Mweemba, Aggrey; Abongomera, George; Thomason, Margaret J; Easterbrook, Philippa; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I Journal: Lancet infectious diseases Issue: Volume 18:Issue 1(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials. (June 2015) Authors: Thomason, Margaret J; Spyer, Moira J; Joffe, Nicola; Boles, Justine; Burke, Andy; Wilkes, Helen C; Rauchenberger, Mary Journal: Clinical investigation Issue: Volume 5:Number 6(2015) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Whole blood versus red cell concentrates for children with severe anaemia: a secondary analysis of the Transfusion and Treatment of African Children (TRACT) trial. Issue 3 (March 2022) Authors: George, Elizabeth C; Uyoga, Sophie; M'baya, Bridon; Kyeyune Byabazair, Dorothy; Kiguli, Sarah; Olupot-Olupot, Peter; Opoka, Robert O; Chagaluka, George; Alaroker, Florence; Williams, Thomas N; Bates, Imelda; Mbanya, Dora; Gibb, Diana M; Walker, A Sarah; Maitland, Kathryn; Maitland, Kathryn; Walke... Journal: Lancet Issue: Volume 10:Issue 3(2022) Page Start: e360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗